维普中文期刊产品整合服务
36篇 您的检索式:作者名="Pokov"
    题名 作者 年代 出处 被引量
1Electrical and optical properties of single crystals of ferroelectrics with a diffused phase transition显示文摘Pokov V A Mylnikova I E 1961SOv Phys Solid State (Engl Transl)1961,3,3:1
2Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart disease显示文摘Serebruany VL Miller M Pokov AN 2006Am J Cardiol2006,97,9:1
3Effect of statins on platelet PAR- I thromhin receptor in patients with the metabolic syndrome (from the PAR - 1 inhibition by statins study) 显示文摘Serebruany VL Miller M Pokov AN 2006Am J Cardiol2006,97,9:1
4Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease显示文摘Serebruany V Pokov I Kuliczkowski W 2008Thromb Haemost2008,100,1:1
5Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease显示文摘Serebruany V Pokov I Kuliczkowski W 2008Thromb Haemost2008,100,1:1
6Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with for without aspirin in patients with type 2 diabetes and a history of transient ischemic attack:a randomized, single-blind, 30- day trial显示文摘Serebruany VL Malinin AI Pokov AN 2008Clin Ther2008,30,2:1
7Effects of extended-release dipyridamole in vitro on thrombin indices measured by calibrated automated thrombography in poststroke survivors显示文摘Serebruany V Sani Y Pokov I 2012Am J Ther2012,19,6:1
8Baseline platelet activity and response after clopidogrel in 257diabetics among 822patients with coronary artery disease显示文摘SEREBRUANY V POKOV I KULICZKOWSKI W 2008Thromb Haemost2008,100,:1
9Baseline platelet activity and response after clopidogrel in257diabetics among822patients with coronary artery disease显示文摘Serebmany V Pokov I Kuliczkowski W et a1 2008Thromb Haemost2008,100,11:1
10Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial显示文摘Serebruany VL Malinin AI Pokov AN 2008Clin Ther2008,30,:1
11Clopidogrel, prasugrel, ticagrelor or vorapaxar in patients with renal impairment: do we have a winner 显示文摘Serebruany VL Tomek A Pokov AN 2015Expert Rev Cardiovasc Ther2015,13,12:1
12Effect of statins on platelet PAR-1 thrombin receptor in patients with the metabolic syndrome ( from the PAR-1 inhibition by statins study) 显示文摘Serebruany V L Miller M Pokov A N 2006Am J C ardiol2006,97,9:1
13Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial显示文摘Serebruany VL Malinin AI Pokov A 2008Am Heart J2008,155,1:1
14Validation of a Veri- fyNow -P2Y12 cartridge for monitoring platelet inhibition with clo- pidogrel 显示文摘MALININ A POKOV A SWAIM L 2006Methods Find Exp Clin Pharmacol2006,28,5:1
15Study of twin-roll cast Aluminium alloys subjected to severe plastic deformation by equal channel angular pressing显示文摘M Poková M Cieslar 2014IOP Conference Series: Materials Science and Engineering2014,,:1
16Monitoring platelet inhibition after clopidogrel with the Verify Now -P2Y12? rapid analyzer: The VERIfy Thrombosis risk ASsessment (VERITAS) study显示文摘Alex Malinin Alex Pokov Malcolm Spergling Anthony Defranco Kenneth Schwartz Dianne Schwartz Ehtisham Mahmud Dan Atar Victor Serebruany 2006Thrombosis Research2006,,:1
17Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease显示文摘Serebruany V Pokov I Kuliczkowski W 2008Thromb Haemost2008,100,1:1
18Valsartan inhibits platelet activity at different doses in mild to moderate hypertensives: Valsartan lnhihits Platelets (VIP)trial 显示文摘SEREBRUANY VL POKOV AN MALININ AI 2006Am Heart J2006,151,1:1
19Early impact of prescription Omega - 3 fatty acids on platelet biomarkers in patients with coronary artery disease and hypertriglyceridemia 显示文摘Serebruany V L Miller M Pokov A N 2011Cardiology2011,118,3:1
20Valsartan inhibits platelet activity at different doses in mild to moderate hypertensives: Valsartan inhibits platelets (VIP) trial 显示文摘Serebruany V L Pokov A N Malinin A I 2006Am Heart J2006,151,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费